"Kallikrein" Related Products

Plasma Kallikrein Inhibitor Screening Kit (Colorimetric)

Cat.No.: Kit-2364
Product Overview: Plasma Prekallikrein (EC 3.4.21.34), is the glycosylated single chain zymogen precursor of the plasma serine protease Kallikrein (PK). It circulates with kininogen and is activated by Factor XIIa to Kallikrein in the intrinsic coagulation pathway. Kallikrein activates plasminogen in fibrinolysis and cleaves kininogen in the bradykinin system of vasodilation. Prekallikrein deficiency is rare and causes increased activated partial thromboplastin time. Elevated plasma Prekallikrein is associated with diabetes and cardiovascular disease. Plasma Kallikrein inhibitors have been proposed as drugs to manage Hereditary Angioedema.Plasma Kallikrein Inhibitor Screening Kit utilizes the ability of active Plasma Kallikrein to cleave a synthetic pNA-based peptide substrate to release pNA (OD405 nm), which can be easily quantified using a microplate reader. In the presence of a Plasma Kallikrein inhibitor, the cleavage of this substrate is reduced/abolished resulting in decrease or total loss of the pNA absorbance. This simple and high-throughput adaptable assay kit can be used to screen/study/characterize potential inhibitors of Plasma Kallikrein.
Applications: Screening/characterizing/studying Plasma Kallikrein inhibitors/activators
Storage: -20°C
Shipping: Gel Pack
Size: 100 assays
Kit Components: PK Assay Buffer; Human PK; PK Substrate; PK Inhibitor (1 mU/μl)
Target Species: Mammalian
Detection method: Colorimetric (OD 405 nm)
Features & Benefits: Simple and reliable test to screen Plasma Kallikdrein inhibitors/activators; High-throughput compatible; Includes Inhibitor Control

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.